Case report highlights pembrolizumab's role in inducing autoimmune epilepsy, suggesting a new risk in cancer treatment.
This case report describes a novel adverse effect of pembrolizumab causing autoimmune epilepsy due to GAD65 autoantibodies.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: